A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence.
作者信息
Boyce Ross M, Shook-Sa Bonnie E, Aiello Allison E
机构信息
Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
出版信息
Clin Infect Dis. 2021 Nov 2;73(9):e3124-e3126. doi: 10.1093/cid/ciaa1868.
Abstract
摘要
相似文献
1
A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence.两项研究的故事：研究设计与我们对严重急性呼吸综合征冠状病毒2血清流行率的理解
Clin Infect Dis. 2021 Nov 2;73(9):e3124-e3126. doi: 10.1093/cid/ciaa1868.
2
Seroprevalence of SARS-CoV-2 infection among hospitalized children at a tertiary care center in North-East India.印度东北部一家三级护理中心住院儿童中SARS-CoV-2感染的血清流行率。
J Trop Pediatr. 2025 Feb 5;71(2). doi: 10.1093/tropej/fmaf007.
3
Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.非洲抗 SARS-CoV-2 抗体的血清流行率：系统评价和荟萃分析。
Rev Med Virol. 2022 Mar;32(2):e2271. doi: 10.1002/rmv.2271. Epub 2021 Jul 6.
4
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening Specimens.根据新生儿筛查样本估算的马萨诸塞州严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清流行趋势。
Clin Infect Dis. 2022 Aug 24;75(1):e105-e113. doi: 10.1093/cid/ciac158.
5
The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那斯普斯卡共和国第二轮基于人群的抗SARS-CoV-2抗体血清流行率研究及新冠疫苗接种评估
Influenza Other Respir Viruses. 2025 Jan;19(1):e70053. doi: 10.1111/irv.70053.
6
Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2.感染严重急性呼吸综合征冠状病毒 2 后 Spike 蛋白抗体的长期持久性和抗体动力学的预测建模。
Clin Infect Dis. 2022 Apr 9;74(7):1220-1229. doi: 10.1093/cid/ciab607.
7
Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.埃塞俄比亚2019冠状病毒病抗体血清流行率：2021年全国人口调查结果
PLoS One. 2025 May 6;20(5):e0313791. doi: 10.1371/journal.pone.0313791. eCollection 2025.
8
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.2020 年 3 月至 2021 年 8 月期间印度 SARS-CoV-2 血清 IgG 抗体的流行率：系统评价和荟萃分析。
Int J Infect Dis. 2022 Mar;116:59-67. doi: 10.1016/j.ijid.2021.12.353. Epub 2021 Dec 28.
9
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV.成人艾滋病病毒感染者中严重急性呼吸综合征冠状病毒2抗体的流行情况
AIDS. 2025 Jul 15;39(9):1178-1184. doi: 10.1097/QAD.0000000000004180. Epub 2025 Mar 13.
10
Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020.2020 年 11 月，法罗群岛未检出的 COVID-19 病例中血清抗体阳性率较低。
Emerg Infect Dis. 2022 Jan;28(1):242-244. doi: 10.3201/eid2801.210917. Epub 2021 Nov 10.
引用本文的文献
1
Estimation of SARS-CoV-2 Seroprevalence in Central North Carolina: Accounting for Outcome Misclassification in Complex Sample Designs.北卡罗来纳州中部估计 SARS-CoV-2 血清流行率：在复杂样本设计中考虑结果的错误分类。
Epidemiology. 2023 Sep 1;34(5):721-731. doi: 10.1097/EDE.0000000000001625. Epub 2023 Jul 31.
2
Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July-August 2020.2020 年 7 月至 8 月，科罗拉多州丹佛市通过社区调查和剩余标本评估 SARS-CoV-2 血清流行率。
Public Health Rep. 2022 Jan-Feb;137(1):128-136. doi: 10.1177/00333549211055137. Epub 2021 Nov 9.
3
SARS-CoV-2 infection in central North Carolina: Protocol for a population-based longitudinal cohort study and preliminary participant results.北卡罗来纳州中部的 SARS-CoV-2 感染：一项基于人群的纵向队列研究方案及初步参与者结果。
PLoS One. 2021 Oct 25;16(10):e0259070. doi: 10.1371/journal.pone.0259070. eCollection 2021.
4
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.基于德国波恩的一项人群研究的 SARS-CoV-2 中和抗体的血清阳性率和相关因素。
Nat Commun. 2021 Apr 9;12(1):2117. doi: 10.1038/s41467-021-22351-5.
本文引用的文献
1
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
2
Racial Disparities in Incidence and Outcomes Among Patients With COVID-19.COVID-19 患者的发病和结局中的种族差异。
JAMA Netw Open. 2020 Sep 1;3(9):e2021892. doi: 10.1001/jamanetworkopen.2020.21892.
3
Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020.由于对 COVID-19 的担忧而延迟或避免就医-美国，2020 年 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257. doi: 10.15585/mmwr.mm6936a4.
4
Challenges and Controversies to Testing for COVID-19.新冠病毒检测面临的挑战和争议。
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01695-20.
5
Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.无代表性的估计：早期严重急性呼吸综合征冠状病毒 2 血清流行率研究及前进道路。
J Infect Dis. 2020 Sep 1;222(7):1086-1089. doi: 10.1093/infdis/jiaa429.
6
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.估计的社区 SARS-CoV-2 抗体血清流行率-佐治亚州两个县，2020 年 4 月 28 日-5 月 3 日。
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):965-970. doi: 10.15585/mmwr.mm6929e2.
7
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.基于全州随机样本的 SARS-CoV-2 感染人群现患率——印第安纳州，2020 年 4 月 25 日-29 日。
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):960-964. doi: 10.15585/mmwr.mm6929e1.
8
Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.无症状 SARS-CoV-2 感染的流行情况：一项叙述性综述。
Ann Intern Med. 2020 Sep 1;173(5):362-367. doi: 10.7326/M20-3012. Epub 2020 Jun 3.
Zotero 插件